Pooled Analysis of Pralatrexate Single-Agent Studies in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
In conclusion, these pooled analysis results further support using pralatrexate in patients with r/r PTCL. Prospective studies are needed to confirm the findings of subgroups analyses.PMID:38429077 | DOI:10.1182/bloodadvances.2023010441 (Source: Adv Data)
Source: Adv Data - March 1, 2024 Category: Epidemiology Authors: Owen A O'Connor Bor-Sheng Ko Ming-Chung Wang Dai Maruyama Yuqin Song Ee Min Yeoh Nick Manamley Kensei Tobinai Source Type: research

Cancers, Vol. 16, Pages 937: Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients
Conclusion: Despite that the newly diagnosed MF patients anticipate a positive treatment effect, few improvements in QoL and symptom reduction were found. These data can be used for adequate expectation management and provide a rationale for further evaluation of treatment regimens in these patients. (Source: Cancers)
Source: Cancers - February 26, 2024 Category: Cancer & Oncology Authors: Rosanne Ottevanger Sylvia van Beugen Juliette M. Kersten Andrea W. M. Evers Maarten H. Vermeer Rein Willemze Koen D. Quint Tags: Article Source Type: research

Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma
Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093/bjd/ljae085. Online ahead of print.NO ABSTRACTPMID:38390970 | DOI:10.1093/bjd/ljae085 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 23, 2024 Category: Dermatology Authors: Romain Stammler Van Anh Ta Elisabeth Cohen Caroline Ram-Wolff Aliz ée Bozonnat Gilles Battesti Baptiste Louveau Samia Mourah Maxime Battistella H élène Moins-Teisserenc Ad èle de Masson Source Type: research

Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma
Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093/bjd/ljae085. Online ahead of print.NO ABSTRACTPMID:38390970 | DOI:10.1093/bjd/ljae085 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 23, 2024 Category: Dermatology Authors: Romain Stammler Van Anh Ta Elisabeth Cohen Caroline Ram-Wolff Aliz ée Bozonnat Gilles Battesti Baptiste Louveau Samia Mourah Maxime Battistella H élène Moins-Teisserenc Ad èle de Masson Source Type: research

Experience with bexarotene to treat cutaneous T-cell lymphomas: a study of the Spanish Working Group of Cutaneous Lymphomas
CONCLUSIONS: Our study confirms bexarotene is a safe and effective therapy for the long-term treatment of CTCL.PMID:38395224 | DOI:10.1016/j.ad.2023.12.007 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - February 23, 2024 Category: Dermatology Authors: R Izu-Belloso I Gainza-Apraiz P Ortiz-Romero O Servitje-Bedate R Fern ández de Misa-Cabrera Y Pe ñate-Santana B Hernandez-Machin T Estrach-Panella M Llamas-Velasco J I Yanguas-Bayona M Morillo-Andujar E Acebo-Mari ñas S Perez-Gala J C Armario-Hita P Sa Source Type: research